Navigation Links
Mayo Clinic researchers: Insulin-boosting medication does not impair ability to survive heart attack
Date:11/5/2007

ORLANDO, Fla. -- Mayo Clinic researchers helped clarify a growing concern about the link between diabetes mellitus treatments and heart attack with the first large, population-based study showing that a group of common medications does not reduce diabetic patients heart attack survival rates. These results were presented today at the American Heart Associations Scientific Sessions 2007 in Orlando, Fla.

The drugs studied are called sulfonylureas and include several commonly used pills to increase insulin release to lower blood sugar. Second-generation sulfonylureas -- known collectively as SU2 -- include glimepiride (Amaryl), glipizide (Glucotrol, Glucotrol XL), and glyburide (DiaBeta, Micronase, Glynase).(1)

Significance of the Mayo Clinic Study

The prevalence of diabetes mellitus is growing rapidly, and physicians need evidence for their treatment recommendations. Worldwide, the number of diabetics is projected to more than double in three decades, from 171 million in 2000 to 366 million in 2030.(2) Many patients with diabetes are at increased risk for heart failure. This complicates their treatment, and has raised concern in recent years among some physicians that SU2s may impair the hearts ability to withstand stress, thus reducing patients ability to survive heart attacks, says Veronique Roger, M.D., M.P.H., the Mayo cardiologist and epidemiologist who led the study.

The Mayo study is the first to use a broad population of community members to extract information about the impact of various diabetes treatments on patients health after heart attack. The Mayo group evaluated the outcome of heart attack in two groups: people who had diabetes and those who did not. Group members were similar in terms of age, gender and lifestyle habits such as smoking. In the diabetes group, researchers tracked patient outcome after heart attack in patients taking three different treatment approaches to lowering blood sugar: SU2 dr
'/>"/>

Contact: Traci Klein
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Radiologists encouraged to look beyond cancer for clinically unseen diseases
3. Clinical depression linked to abnormal emotional brain circuits
4. Preclinical study suggests organ-transplant drug may aid in lupus fight
5. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
6. AASM encourages those student-athletes at risk for developing osa to visit a sleep clinic
7. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
8. MinuteClinic Becomes Participating Provider with Assurant Health
9. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
10. Acupuncturists Relocation Tightens Relationship With Fertility Clinic
11. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... The festival season is coming soon. The high-end fashion designer ... cocktail dresses . A lot of sophisticated women like its ... new promotion for its high quality clothes. Now, each of ... 20 to 71 percent off. , The company’s cocktail ... provided in many fashionable colors. Mary, the company’s sales manager, ...
(Date:9/20/2014)... September 20, 2014 Recently, Best ... site, has launched its new website. The new ... of popular hosting products for customers. Here, people ... make a purchasing decision. Also, it has recommended ... , One of the great web hosting ...
(Date:9/20/2014)... September 20, 2014 Plumbing construction ... out of 5, indicating a moderately favorable purchasing environment ... score reflects current and future pricing trends that will ... prices. Other factors that negatively affect buyer power are ... construction and the moderate switching costs. Buyers benefit, however, ...
(Date:9/20/2014)... 20, 2014 The Arizona Advanced ... is celebrating National Manufacturing Day by opening its doors ... processing and additive manufacturing labs will be offered between ... at MCC’s Southern and Dobson campus (1833 W. Southern ... Lot D. , The AzAMI at MCC was established ...
(Date:9/19/2014)... (PRWEB) September 20, 2014 Nearly 780 ... of Common Pleas where a meeting took place to ... complaints pending in the court’s mass tort program. ... meet this past week at the Complex Litigation Center ... consolidated for pretrial proceedings. The Risperdal lawsuits filed against ...
Breaking Medicine News(10 mins):Health News:High-end Fashion Designer BellasDress Offers Luxurious Cocktail Dresses For Sophisticated Women 2Health News:Best Cheap Hosting USA Launches Its New Website And Recommends InMotion To Worldwide People 2Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 2Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 3Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 4Health News:National Manufacturing Day Open House at Mesa Community College Oct. 3 2Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 2Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 3Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 4
... the future may be painless and noninvasive, thanks to smart ... test for skin cancer, patients today must endure doctors cutting ... lab and anxiously awaiting the results. Using laser microscopes that ... have the tools to painlessly scan a patient,s troublesome mole ...
... have discovered a signaling pathway that is crucial to ... data, obtained from cells, animals and ALI patients, suggest ... the targets significantly reduced flooding of the lungs that ... is a devastating disease, with 40 percent mortality and ...
... Researchers at Memorial Sloan-Kettering Cancer Center,s Nanotechnology ... Hybrid Silica Technologies, have received approval for their ... US Food and Drug Administration (FDA) for an ... imaging of cancer, which may be useful for ...
... a patient,s immune system and enables them to fight the ... first time in the UK. The treatment will use ... of Southampton, which will treat a selected group of volunteers ... forms of bone marrow and blood cancer. Scientists ...
... MONDAY, Jan. 31 (HealthDay News) -- A man is much more ... another woman than a girlfriend who had sex with another man, ... to stick with a man who had sex with another woman ... The findings provide new insight into the general male desire to ...
... Sprint Fidelis implantable cardioverter-defibrillator (ICD) leads (Medtronic) failed more ... heart disease, according to a multicenter study published online ... that lead failure was not associated with death or ... the patients whose leads fractured experienced painful inappropriate shocks, ...
Cached Medicine News:Health News:Smart lasers could make cancer biopsies painless, help speed new drugs to market 2Health News:Researchers discover signaling pathway crucial to acute lung injury 2Health News:Cancer-targeting investigational nanoparticle receives FDA IND approval for first-in-human trial 2Health News:Cancer-targeting investigational nanoparticle receives FDA IND approval for first-in-human trial 3Health News:Southampton scientists begin patient trials of new leukemia cancer vaccine 2Health News:Southampton scientists begin patient trials of new leukemia cancer vaccine 3Health News:Recalled ICD leads fail in women, youths most often 2
(Date:9/19/2014)... , Sept. 19, 2014 UBM Medica ... a leading online community to help oncologists and other ... available regarding the use of targeted therapies and immunotherapies, ... research and treatment.  Every September, ... way to raise awareness about blood cancers—helping to increase ...
(Date:9/19/2014)... DALLAS , September 19, 2014 ... Market by Equipment Type (Benchtop, Mobile, Industrial, & ... Others), Technology (Tray-style, Manifold, & Rotary) & Geography ... by MarketsandMarkets, defines and segments the lyophilization market ... regions with analyses and projections of the market ...
(Date:9/19/2014)...  Lpath, Inc. (NASDAQ: LPTN ), ... today that it has entered into definitive agreements ... and 3,605,042 unregistered warrants in a registered direct ... share of common stock and one unregistered warrant ... will be $3.475.  The warrants have an exercise ...
Breaking Medicine Technology:OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3
... , , FARMINGDALE, N.Y., Jan. 11 Misonix, ... invasive ultrasonic medical device technology, which in Europe is ... other acute health conditions, has entered into a new, ... in Lima, Peru, for the distribution of the SonaStar(TM) ...
... , BETHESDA, Md., Jan. 11 Spherix Inc. (Nasdaq: ... a provider of technical and regulatory consulting services to food, ... Dr. Robert Lodder, will be presenting at the Annual OneMedPlace ... Drake Hotel in San Francisco, CA. Dr. Lodder will ...
Cached Medicine Technology:Misonix Announces New Distribution Agreement for Peru 2Misonix Announces New Distribution Agreement for Peru 3Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco 2Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco 3
... with obstructive sleep apnea necessitating tracheotomy, or ... Also indicated where airway access for pulmonary ... ,Another excellent choice for a sleep apnea ... series. Available with a low profile inner ...
... additional patient safety, the laryngectomy ... integral 15 mm ISO termination ... a ventilator, with or without ... , ,Portex® laryngectomy tubes ...
... nature of the silicone tube material allows ... and more comfort than tubes made of ... comfortable and compliant neck flange allows the ... irritation. A comprehensive range of sizes insures ...
... that in excess of 10% of all ... a specialized tracheostomy tube. Bivona® Fixed-Flange Hyperflex™ ... and can adapt to the unique anatomical ... extra horizontal length, extra vertical length, ...
Medicine Products: